High-temperature
exposure during hot melt extrusion processing
of amorphous solid dispersions may result in thermal degradation of
the drug. Polymer type may influence the extent of degradation, although
the underlying mechanisms are poorly understood. In this study, the
model compound, ritonavir (T
m = 126 °C),
undergoes thermal degradation upon high-temperature exposure. The
extent of degradation of ritonavir in amorphous solid dispersions
(ASDs) formulated with poly(vinylpyrrolidone) (PVP), poly(vinylpyrrolidone)
vinyl acetate copolymer (PVP/VA), hydroxypropyl methylcellulose acetate
succinate (HPMCAS), and hydroxypropyl methylcellulose (HPMC) following
isothermal heating and hot melt extrusion was evaluated, and mechanisms
related to molecular mobility and intermolecular interactions were
assessed. Liquid chromatography–mass spectrometry (LC–MS/MS)
studies were used to determine the degradation products and pathways
and ultimately the drug–polymer compatibility. The dominant
degradation product of ritonavir was the result of a dehydration reaction,
which then catalyzed a series of hydrolysis reactions to generate
additional degradation products, some newly reported. This reaction
series led to accelerated degradation rates with protic polymers,
HPMCAS and HPMC, while ASDs with aprotic polymers, PVP and PVP/VA,
had reduced degradation rates. This work has implications for understanding
mechanisms of thermal degradation and drug–polymer compatibility
with respect to the thermal stability of amorphous solid dispersions.